Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Dialysis disequilibrium syndrome

INTRODUCTION

The dialysis disequilibrium syndrome (DDS) is an increasingly rare syndrome characterized by neurologic symptoms of varying severity that affect dialysis patients, particularly when they are first started on hemodialysis [1,2]. It is thought to be due primarily to cerebral edema.

This topic reviews DDS. Issues related to mental status changes and other acute problems during dialysis are presented separately. (See "Acute complications during hemodialysis" and "Psychiatric illness in dialysis patients" and "Seizures in patients undergoing hemodialysis".)

EPIDEMIOLOGY AND RISK FACTORS

The incidence of DDS is poorly defined and varies according to the patient population. Most reports state that the incidence has declined [2-4]. Severe DDS is now rare in adults because of the standard use of the preventive recommendations made below (see 'Prevention' below). Another possible reason for the decreased incidence is that patients are generally initiated on dialysis at a much lower blood urea concentration than previously [3]. However, some reports suggest that the syndrome is underreported because of the broad spectrum of manifestations [5]. Less severe symptoms (such as muscle cramps and dizziness) may reflect DDS, but are often not reported.

Risk factors for DDS include the following [2-6]:

First dialysis treatment

        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2014. | This topic last updated: Nov 21, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Kennedy AC, Linton AL, Eaton JC. Urea levels in cerebrospinal fluid after haemodialysis. Lancet 1962; 1:410.
  2. Arieff AI. Dialysis disequilibrium syndrome: current concepts on pathogenesis and prevention. Kidney Int 1994; 45:629.
  3. Zepeda-Orozco D, Quigley R. Dialysis disequilibrium syndrome. Pediatr Nephrol 2012; 27:2205.
  4. Patel N, Dalal P, Panesar M. Dialysis disequilibrium syndrome: a narrative review. Semin Dial 2008; 21:493.
  5. Bagshaw SM, Peets AD, Hameed M, et al. Dialysis Disequilibrium Syndrome: brain death following hemodialysis for metabolic acidosis and acute renal failure--a case report. BMC Nephrol 2004; 5:9.
  6. Marshall MR, Golper TA. Low-efficiency acute renal replacement therapy: role in acute kidney injury. Semin Dial 2011; 24:142.
  7. Esnault P, Lacroix G, Cungi PJ, et al. Dialysis disequilibrium syndrome in neurointensive care unit: the benefit of intracranial pressure monitoring. Crit Care 2012; 16:472.
  8. Kliger AS. Complications of dialysis: Hemodialysis, peritoneal dialysis, CAPD. In: Fluid, Electrolyte, and Acid-Base Disorders, Arieff AI, DeFronzo RA (Eds), Churchill-Livingstone, New York 1985. p.777.
  9. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361:1627.
  10. Silver SM, DeSimone JA Jr, Smith DA, Sterns RH. Dialysis disequilibrium syndrome (DDS) in the rat: role of the "reverse urea effect". Kidney Int 1992; 42:161.
  11. Silver SM, Sterns RH, Halperin ML. Brain swelling after dialysis: old urea or new osmoles? Am J Kidney Dis 1996; 28:1.
  12. Galons JP, Trouard T, Gmitro AF, Lien YH. Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic resonance imaging. J Clin Invest 1996; 98:750.
  13. Trinh-Trang-Tan MM, Cartron JP, Bankir L. Molecular basis for the dialysis disequilibrium syndrome: altered aquaporin and urea transporter expression in the brain. Nephrol Dial Transplant 2005; 20:1984.
  14. Ali II, Pirzada NA. Neurologic complicatiosn associated with dialysis and chronic renal insufficiency. In: Principles and Practice of Dialysis, Henrich WL (Ed), Lippincott, Williams & Wilkins, Philadelphia 2004. p.507.
  15. Silver SM. Cerebral edema after rapid dialysis is not caused by an increase in brain organic osmolytes. J Am Soc Nephrol 1995; 6:1600.
  16. Pagel MD, Ahmad S, Vizzo JE, Scribner BH. Acetate and bicarbonate fluctuations and acetate intolerance during dialysis. Kidney Int 1982; 21:513.
  17. Rodrigo F, Shideman J, McHugh R, et al. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med 1977; 86:554.
  18. Van Stone JC, Meyer R, Murrin C, Cook J. Hemodialysis with glycerol dialysate. Trans Am Soc Artif Intern Organs 1979; 25:354.
  19. Glenn CM, Astley SJ, Watkins SL. Dialysis-associated seizures in children and adolescents. Pediatr Nephrol 1992; 6:182.
  20. Bergman H, Daugirdas JT, Ing TS. Complications during hemodialysis. In: Handbook of Dialysis, Daugirdas JG, Blake PG, Ing TS (Eds), Lippincott, Williams & Wilkins, Philadelphia 2001. p.158.